Mersana Therapeutics, Inc. (32)

Browse by Contract Category

Contracts

Sales Agreement dated November 7, 2022 by and between the Company and Cowen and Company, LLC (Filed With SEC on November 7, 2022)
Offer Letter, dated June 15, 2021, between the Company and Tushar Misra (Filed With SEC on May 9, 2022)
First Amendment to Loan and Security Agreement, dated February 17, 2022, between Oxford Finance LLC, the Lenders named therein including Silicon Valley Bank, and the Company (Filed With SEC on May 9, 2022)
Amendment No. 1 to the Amended and Restated Commercial License and Option Agreement, dated February 2, 2022, between the Company and Synaffix B.V (Filed With SEC on May 9, 2022)
Form of Non-statutory Stock Option under the 2022 Inducement Stock Incentive Plan (Filed With SEC on February 28, 2022)
Eighth Lease Modification Agreement to the Lease Between Rivertech Associates II LLC and Mersana Therapeutics, Inc., effective as of April 5, 2021, by and between Mersana... (Filed With SEC on May 10, 2021)
Offer Letter, dated March 5, 2021, between the Company and Alejandra Carvajal (Filed With SEC on May 9, 2022)
Research Collaboration and License Agreement, dated February 2, 2022, between the Company and Janssen Biotech, Inc (Filed With SEC on May 9, 2022)
Sales Agreement dated February 28, 2022 by and between the Company and Cowen and Company, LLC (Filed With SEC on February 28, 2022)
Form of Inducement Restricted Stock (Filed With SEC on February 28, 2022)
2022 Inducement Stock Incentive Plan (Filed With SEC on February 28, 2022)
Amended and Restated Commercial License and Option Agreement, dated November 23, 2021, by and between Synaffix B.V. and Mersana Therapeutics, Inc (Filed With SEC on February 28, 2022)
Loan and Security Agreement, dated October 29, 2021, by and between Oxford Finance LLC, Silicon Valley Bank and Mersana Therapeutics, Inc (Filed With SEC on February 28, 2022)
Second Amendment to the License, Development and Commercialization Agreement, dated September 28, 2021, by and between Mersana Therapeutics, Inc. and Recepta Biopharma S.A.... (Filed With SEC on November 9, 2021)
Form of Restricted Stock Unit under the 2017 Stock Incentive Plan (Filed With SEC on August 6, 2021)
Amended and Restated Offer Letter, by and between Mersana Therapeutics, Inc. and Michael Kaufman, dated March 8, 2017 (Filed With SEC on May 10, 2021)
Offer Letter, by and between Mersana Therapeutics, Inc. and Arvin Yang, dated November 5, 2020 (Filed With SEC on May 10, 2021)
Second Amendment to Loan and Security Agreement, dated August 28, 2020, by and between Mersana Therapeutics, Inc, and Silicon Valley Bank (Filed With SEC on September 3, 2020)
Commercial License and Option Agreement (Filed With SEC on August 7, 2020)
Underwriting Agreement, dated May 28, 2020, among Mersana Therapeutics, Inc. and Cowen and Company, LLC and SVB Leerink LLC, as representatives of the several underwriters listed... (Filed With SEC on June 1, 2020)
Offer Letter, by and between Mersana Therapeutics, Inc. and Brian DeSchuytner, dated June 10, 2019 (Filed With SEC on May 8, 2020)
Offer Letter, by and between Mersana Therapeutics, Inc. and Dirk Huebner, dated November 5, 2018 (Filed With SEC on May 8, 2020)
Seventh Lease Extension and Modification Agreement to the Lease Between Rivertech Associates II LLC and Mersana Therapeutics, Inc. dated March 10 2020, by and between Mersana... (Filed With SEC on May 8, 2020)
Description of Registrants Common Stock (Filed With SEC on February 28, 2020)
Exchange Agreement between Mersana Therapeutics, Inc. and Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P. and Biotechnology Value Trading Fund OS, L.P., dated... (Filed With SEC on November 27, 2019)
Form of Exchange Warrant (Filed With SEC on November 27, 2019)
First Amendment to the License, Development and Commercialization Agreement dated August 19, 2019, by and between Mersana Therapeutics, Inc. and Recepta Biopharma, S.A (Filed With SEC on November 6, 2019)
First Amendment to Loan and Security Agreement, dated June 21, 2019, by and between Mersana Therapeutics, Inc. and Silicon Valley Bank (Filed With SEC on August 8, 2019)
Loan and Security Agreement dated May 8, 2019, by and between Mersana Therapeutics, Inc. and Silicon Valley Bank (Filed With SEC on August 8, 2019)
Offer Letter, by and between Mersana Therapeutics, Inc. and David Spellman, dated December 18, 2017 (Filed With SEC on May 9, 2019)
Loan and Security Agreement dated May 8, 2019, by and between Mersana Therapeutics, Inc. and Silicon Valley Bank (Filed With SEC on May 9, 2019)
Underwriting Agreement, dated February 28, 2019, by and among Mersana Therapeutics, Inc. and SVB Leerink LLC, as the representative of the several underwriters listed on Schedule... (Filed With SEC on March 4, 2019)